This episode of the London Futurists Podcast features Dr. Emil Kendziorra, a pioneer in cryopreservation and longevity science. Dr. Kendziorra discusses his journey from medical research to entrepreneurship and his commitment to advancing cryomedicine through his organizations, Tomorrow Bio and the European Biostasis Foundation.

Key Points:

Cryopreservation offers a unique bridge between current medical limitations and future possibilities. Dr. Kendziorra's work highlights the potential to preserve life while awaiting breakthroughs in longevity science. This emerging field invites us to rethink our approach to death and the future of humanity.

• Background and Motivation: Dr. Kendziorra transitioned from cancer research to entrepreneurship due to frustration with the slow progress of academic longevity science. This pivot enabled him to fund and focus on cryopreservation, a field he believes can make immediate impacts on life extension.
• Cryopreservation as a Practical Solution: While curing diseases is the ultimate goal, cryopreservation offers an actionable option today, providing a chance to preserve patients until advanced treatments or revival techniques are developed.
• Tomorrow Bio's Innovations: Unlike traditional cryonics, Tomorrow Bio employs "whole-body field cryoprotection," where the preservation process begins at the site of death. This approach enhances quality and reduces degradation risks.
• Affordability and Accessibility: Cryopreservation costs €75,000 for brain-only preservation and €200,000 for whole-body preservation. Most clients fund these through life insurance, making the service more accessible over time.
• Ethical and Logistical Challenges: The field faces challenges such as legal frameworks, societal skepticism, and the unpredictable nature of death. However, innovative strategies, such as mobile operating units, address logistical hurdles.
• Future Goals: Dr. Kendziorra aims to standardize high-quality cryopreservation, establish more storage facilities globally, and advance research to enable the revival of preserved mammals within decades.